神经母细胞瘤
血癌
医学
疾病
小儿肿瘤学
小儿癌症
肿瘤科
癌症
病理
癌症研究
内科学
遗传学
生物
细胞培养
作者
Andrés Morales La Madrid,Melanie Beglin Nall,Karen Ouyang,Agata Minor,Gordana Raca,Paul Kent,Ira Miller,Gudrun Schleiermacher,Isabelle Janoueix‐Lerosey,Susan L. Cohn
摘要
Abstract Surgery alone is curative for most children with localized MYCN ‐non‐amplified neuroblastoma. However, 10–15% will develop recurrent loco‐regional disease, and very rarely, patients will relapse metastatically. Currently, it is not possible to predict which child with localized, MYCN ‐non‐amplified neuroblastoma will develop disseminated disease. We report two children who presented with favorable biology, localized neuroblastoma and subsequently relapsed with metastatic disease after treatment with surgery. Whole‐genome DNA copy number analyses performed on the diagnostic tumors identified 15 (case 1) and 8 (case 2) segmental chromosomal alterations. Further analysis of the prognostic value of whole‐genome analysis in children with localized neuroblastoma is warranted. Pediatr Blood Cancer 2013;60:332–335. © 2012 Wiley Periodicals, Inc.
科研通智能强力驱动
Strongly Powered by AbleSci AI